E. coli NfsA: an alternative nitroreductase for prodrug activation gene therapy in combination with CB1954

Simon Vass, David Jarrom, WR Wilson, Eva Hyde, Peter Searle

Research output: Contribution to journalArticlepeer-review

34 Citations (Scopus)
143 Downloads (Pure)

Fingerprint

Dive into the research topics of 'E. coli NfsA: an alternative nitroreductase for prodrug activation gene therapy in combination with CB1954'. Together they form a unique fingerprint.

Medicine & Life Sciences